Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas

The PI3K (phosphatidylinositol-3-kinase)/mTOR (mammalian target of rapamycin) pathway is frequently activated in endometrial cancer through various PI3K/AKT-activating genetic alterations. We examined the antitumor effect of NVP-BEZ235—a dual PI3K/mTOR inhibitor—and RAD001—an mTOR inhibitor—in 13 en...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Shoji, Keiko, Oda, Katsutoshi, Kashiyama, Tomoko, Ikeda, Yuji, Nakagawa, Shunsuke, Sone, Kenbun, Miyamoto, Yuichiro, Hiraike, Haruko, Tanikawa, Michihiro, Miyasaka, Aki, Koso, Takahiro, Matsumoto, Yoko, Wada-Hiraike, Osamu, Kawana, Kei, Kuramoto, Hiroyuki, McCormick, Frank, Aburatani, Hiroyuki, Yano, Tetsu, Kozuma, Shiro, Taketani, Yuji
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2012
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3360787/
https://ncbi.nlm.nih.gov/pubmed/22662154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0037431
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky